Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
rucosopasem manganese
- Development stage
- Phase 1
- Lead developer
- Galera Therapeutics
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Rucosopasem manganese (GC4711) is an investigational, highly selective small molecule that mimics the enzyme superoxide dismutase (SOD) and is bioavailable as a manganese complex. Its mechanism of action involves catalyzing the dismutation of superoxide radicals, converting them into hydrogen peroxide and molecular oxygen, thereby reducing oxidative stress caused by radiotherapy or chemoradiation. Rucosopasem manganese is developed as a next-generation dismutase mimetic, similar to avasopasem manganese (GC4419), and is under clinical development as a radioprotector primarily for the reduction of severe oral mucositis and other toxicities associated with radiation or chemoradiotherapy, particularly in cancer patients. The drug is being developed by Galera Therapeutics and is not currently approved for clinical use.
- Brand names
- rucosopasem manganese
- Other names
- GC4711GC-4711GC 4711
Beyond the preview
Go deeper on rucosopasem manganese.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on rucosopasem manganese.